HCA Board Urges Shareholders to Reject Mayfield Hospital Acquisition Health Study

State Sen. Julie Mayfield's push to force HCA Healthcare to account for the health consequences of its hospital acquisitions, including the 2019 purchase of Asheville's Mission Hospital, has run into a unanimous wall of opposition from the company's board of directors ahead of its April 23, 2026 shareholders' meeting.

In its 2026 definitive proxy statement, HCA's board listed Mayfield's measure as Proposal 4 and flatly rejected it. "We have carefully reviewed Proposal 4 and, for the following reasons, have determined that adopting the proposal is not in the best interests of HCA Healthcare or our stockholders," the board wrote. "The Board unanimously recommends a vote 'Against' the proposal."

Mayfield, a Democrat representing Buncombe County in the North Carolina Senate, filed the proposal as an HCA shareholder. It would require the company to produce a report examining the health consequences of its acquisitions over the past decade, with Mission Hospital serving as the central example. HCA acquired the Asheville facility in 2019.

The board called the proposed report impractical, arguing it would drain company resources without producing meaningful returns for shareholders. "We believe the report called for in this proposal is neither practicable nor a good use of Company resources given its broad scope," the proxy statement reads. "If adopted as proposed, the proposal would result in unnecessary expense and burdens with limited benefit to our stockholders."

In filings submitted to the SEC, HCA's counsel previously sought permission to exclude the proposal from the company's 2025 proxy materials entirely, citing staff precedents including a 2014 Apple case in which regulators concurred with excluding a proposal that demanded detailed cost disclosures tied to specific strategic decisions. Those efforts did not prevent the proposal from appearing in the 2026 proxy.

Mayfield pushed back against characterizations of her motives in filings included with the SEC submission. "I fail to see how I personally benefit and other shareholders do not by requesting that the report included in my Proposal be commissioned and publicized," she wrote. She also addressed arguments that her role as a state senator disqualified her from using the shareholder proposal process: "Although I am a North Carolina State Senator, my position as an elected official does not preclude me from having passions or advocating for issues (such as healthcare), and it should not preclude me, as a shareholder in the Company, from including a proposal in the Company's proxy statement pursuant to Rule 14a-8."

The board countered criticism of Mission Hospital's performance by pointing to its clinical recognition record. Mission was among three HCA facilities to receive the 2026 Healthgrades America's 50 Best Hospitals Award, placing it in the top 1 percent of hospitals nationally for consistent clinical excellence. It is the 11th consecutive year Mission has received that distinction from Healthgrades.

The Mayfield proposal was not the only shareholder measure the board opposed. In the same proxy statement, the board unanimously recommended against a separate proposal that would have expanded shareholders' ability to bring concerns directly to the board. That proposal cited Mission Hospital's Immediate Jeopardy sanctions among its supporting arguments.

The April 23 meeting will be held virtually as a live webcast.